Coloplast A/S
CSE:COLO B
Gross Margin
Coloplast A/S
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Gross Margin Across Competitors
| Country | Company | Market Cap |
Gross Margin |
||
|---|---|---|---|---|---|
| DK |
|
Coloplast A/S
CSE:COLO B
|
138.1B DKK |
68%
|
|
| CH |
|
Alcon AG
SIX:ALC
|
34.5B CHF |
54%
|
|
| JP |
|
Hoya Corp
TSE:7741
|
5.9T JPY |
86%
|
|
| US |
|
Align Technology Inc
NASDAQ:ALGN
|
13.5B USD |
70%
|
|
| UK |
|
ConvaTec Group PLC
LSE:CTEC
|
5.9B GBP |
57%
|
|
| CH |
|
Ypsomed Holding AG
SIX:YPSN
|
5.6B CHF |
39%
|
|
| CN |
|
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
|
44.7B CNY |
70%
|
|
| US |
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
5.6B USD |
64%
|
|
| US |
|
Merit Medical Systems Inc
NASDAQ:MMSI
|
5.5B USD |
48%
|
|
| KR |
H
|
HLB Inc
KOSDAQ:028300
|
6.5T KRW |
20%
|
|
| CA |
|
Bausch + Lomb Corp
NYSE:BLCO
|
4.3B USD |
60%
|
Coloplast A/S
Glance View
Coloplast A/S, headquartered in Humlebæk, Denmark, has a storied history that dates back to 1954 when a nurse, Elise Sørensen, identified a crucial need in the healthcare sector. Her sister had undergone ostomy surgery, and the lack of appropriate post-operative care products inspired Sørensen to design the world’s first adhesive ostomy bag. This innovation laid the groundwork for Coloplast's trajectory in the healthcare industry. Today, the company has expanded its focus to include ostomy care, continence care, wound and skin care, and interventional urology. With a commitment to improving patients' quality of life, Coloplast has become a leader in designing and manufacturing products that not only highlight practicality but also embody comfort and discretion. Coloplast generates revenue through a business model that emphasizes product innovation and direct engagement with healthcare providers and patients. The company invests significantly in research and development to improve and widen its product offerings continuously. It operates globally, distributing its products directly and via partnerships with hospitals, clinics, and healthcare professionals. By maintaining an attentive approach to user experience and incorporating customer feedback into its development processes, Coloplast ensures its portfolio aligns with the actual needs of its users. This user-centered strategy not only enhances customer loyalty but also fortifies the company’s market position, driving its financial success.
See Also
Gross Margin is the amount of money a company retains after incurring the direct costs associated with producing the goods it sells and the services it provides. The higher the gross margin, the more capital a company retains, which it can then use to pay other costs or satisfy debt obligations.
Based on Coloplast A/S's most recent financial statements, the company has Gross Margin of 67.5%.
You don't have any saved screeners yet